What Factors Influence on Dermatology-Related Life Quality of Psoriasis Patients in South Korea?

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2021 Apr 3

PMID 33807295

Citations 8

Authors

So Young Park

Kon Hee Kim

Affiliations

Soon will be listed here.

Abstract

This descriptive study aimed to identify factors that can influence the quality of life of psoriasis patients. A total of 118 psoriasis outpatients completed a questionnaire consisting of the Dermatology Life Quality Index (DLQI), Psoriasis Life Stress Inventory (PLSI), Mishel Uncertainty in Illness Scale-Community form (MUIS-C), Center for Epidemiologic Studies-Depression scale (CES-D), and Self-Reported Severity Score (SRSS). The Psoriasis Area Severity Index (PASI) was calculated. The collected data were analyzed by descriptive statistics, -test, one-way ANOVA, Scheffé test, Pearson's correlation analysis, and stepwise multiple regression using SPSS/WIN 26.0. The average score of the DLQI was 14.19 ± 6.83 (range 0-30); the DLQI showed statistically significant differences according to age (F = 4.02, = 0.021) and smoking type (F = 7.49, = 0.001). The dermatology-related quality of life was significantly affected by psoriasis-related stress (β = 0.37, < 0.001), depression (β = 0.35, < 0.001), and subjective severity (β = 0.19, = 0.005); these variables explained 60.7% of the variance in the dermatology-related quality of life (F = 61.34, < 0.001). The results demonstrated that psoriasis-related stress, depression, and perceived severity of psoriasis should be considered when developing nursing interventions to improve patients' quality of life.

Citing Articles

Determinants of perceived patient benefit in a longitudinal cohort study of patients with psoriasis and atopic dermatitis.

Wintermann G, Abraham S, Peters E, Beissert S, Weidner K Sci Rep. 2025; 15(1):1553.

PMID: 39788997 PMC: 11717929. DOI: 10.1038/s41598-024-84794-2.

A Systematic Review of 207 Studies Describing Validation Aspects of the Dermatology Life Quality Index.

Vyas J, Johns J, Ali F, Ingram J, Salek S, Finlay A Acta Derm Venereol. 2024; 104:adv41120.

PMID: 39508500 PMC: 11559262. DOI: 10.2340/actadv.v104.41120.

Tobacco smoking negatively influences the achievement of greater than three-quarters reduction in psoriasis area and severity index after eight weeks of treatment among patients with psoriasis: Findings from a prospective study.

Qiang Y, Kuai L, Liu S, Xu Q, Shenfan L, Zhang R Tob Induc Dis. 2024; 22.

PMID: 38605857 PMC: 11007762. DOI: 10.18332/tid/184143.

The Influence of Treatment Modalities on the Quality of Life of Psoriasis Patients.

Milidrag A, Safiye T, Gutic M, Zlatanovic M, Stevanovic A, Dubljanin J Iran J Public Health. 2023; 52(9):1925-1934.

PMID: 38033841 PMC: 10682585. DOI: 10.18502/ijph.v52i9.13574.

Factors associated with quality of life in Chinese people with psoriasis: a cross-sectional study.

Zhang X, Lin J, Ou M, Yan H, Liu S, Dai L BMC Public Health. 2023; 23(1):1860.

PMID: 37749489 PMC: 10521450. DOI: 10.1186/s12889-023-16758-6.

References

Fortune D, Richards H, Griffiths C . Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin. 2005; 23(4):681-94. DOI: 10.1016/j.det.2005.05.022. View

Aberra T, Joshi A, Lerman J, Rodante J, Dahiya A, Teague H . Self-reported depression in psoriasis is associated with subclinical vascular diseases. Atherosclerosis. 2016; 251:219-225. PMC: 5305805. DOI: 10.1016/j.atherosclerosis.2016.05.043. View

Gupta M, Gupta A . The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol. 1995; 75(3):240-3. DOI: 10.2340/0001555575240243. View

Devrimci-Ozguven H, Kundakci T, Kumbasar H, Boyvat A . The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol. 2001; 14(4):267-71. DOI: 10.1046/j.1468-3083.2000.00085.x. View

Finlay A, Khan G . Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994; 19(3):210-6. DOI: 10.1111/j.1365-2230.1994.tb01167.x. View

Picardi A, Abeni D . Stressful life events and skin diseases: disentangling evidence from myth. Psychother Psychosom. 2001; 70(3):118-36. DOI: 10.1159/000056237. View

Kurd S, Troxel A, Crits-Christoph P, Gelfand J . The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010; 146(8):891-5. PMC: 2928071. DOI: 10.1001/archdermatol.2010.186. View

Lin T, See L, Shen Y, Liang C, Chang H, Lin Y . Quality of life in patients with psoriasis in northern Taiwan. Chang Gung Med J. 2011; 34(2):186-96. View

Egeberg A, Hansen P, Gislason G, Skov L, Mallbris L . Risk of self-harm and nonfatal suicide attempts, and completed suicide in patients with psoriasis: a population-based cohort study. Br J Dermatol. 2016; 175(3):493-500. DOI: 10.1111/bjd.14633. View

10.

Mazzotti E, Barbaranelli C, Picardi A, Abeni D, Pasquini P . Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis. Acta Derm Venereol. 2005; 85(5):409-13. DOI: 10.1080/00015550510032832. View

11.

Aune D, Snekvik I, Schlesinger S, Norat T, Riboli E, Vatten L . Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2018; 33(12):1163-1178. PMC: 6290660. DOI: 10.1007/s10654-018-0366-z. View

12.

Schmitt J, Ford D . Role of depression in quality of life for patients with psoriasis. Dermatology. 2007; 215(1):17-27. DOI: 10.1159/000102029. View

13.

Mishel M . Reconceptualization of the uncertainty in illness theory. Image J Nurs Sch. 1990; 22(4):256-62. DOI: 10.1111/j.1547-5069.1990.tb00225.x. View

14.

Goyal A, Dey A, Chaturvedi A, Elnabawi Y, Aberra T, Chung J . Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in Psoriasis: A Prospective Cohort Study. JACC Cardiovasc Imaging. 2018; 13(2 Pt 1):465-477. PMC: 6506409. DOI: 10.1016/j.jcmg.2018.08.038. View

15.

Gupta M, Gupta A . Quality of life of psoriasis patients. J Eur Acad Dermatol Venereol. 2001; 14(4):241-2. DOI: 10.1046/j.1468-3083.2000.00134.x. View

16.

Korman A, Hill D, Alikhan A, Feldman S . Impact and management of depression in psoriasis patients. Expert Opin Pharmacother. 2015; 17(2):147-52. DOI: 10.1517/14656566.2016.1128894. View

17.

Lee Y, Park E, Kwon I, Kim K, Kim K . Impact of Psoriasis on Quality of Life: Relationship between Clinical Response to Therapy and Change in Health-related Quality of Life. Ann Dermatol. 2010; 22(4):389-96. PMC: 2991714. DOI: 10.5021/ad.2010.22.4.389. View

18.

Koo J, Marangell L, Nakamura M, Armstrong A, Jeon C, Bhutani T . Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression. J Eur Acad Dermatol Venereol. 2017; 31(12):1999-2009. DOI: 10.1111/jdv.14460. View

19.

Zill J, Dirmaier J, Augustin M, Dwinger S, Christalle E, Harter M . Psychosocial Distress of Patients with Psoriasis: Protocol for an Assessment of Care Needs and the Development of a Supportive Intervention. JMIR Res Protoc. 2018; 7(2):e22. PMC: 5822035. DOI: 10.2196/resprot.8490. View

20.

Kaasa S, Loge J . Quality of life in palliative care: principles and practice. Palliat Med. 2003; 17(1):11-20. DOI: 10.1191/0269216303pm662ra. View